Studying tiny ‘live’ models of the human brain has helped researchers understand its ageing and find a key to potential treatments neurodegenerative diseases.
Researchers studying ageing in tiny ‘live’ models of the human brain have found a key to potential treatments for Alzheimer’s and other neurodegenerative diseases.
Improving a “trial-and-error approach’’ to epilepsy treatment is the aim of research that encompasses stem cells, artificial intelligence, brain organoids and drug screening.
New research from the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland has brought us a step closer to understanding how protein clumps called amyloid plaques contribute to the death of brain cells in Alzheimer’s disease.
The Wolvetang laboratory at AIBN recently found that key areas of the brain affected in this disease can be recreated in the lab using patient-derived stem cells, and this has now been published in the journal Frontiers in Cellular Neuroscience.
Australian Institute for Bioengineering and Nanotechnology (AIBN) researchers will share in more than $2.3 million in new funding announced this week to advance medical initiatives.
The University of Queensland today launched a new $7 million regenerative medicine research centre to improve older Australians’ quality of life and increase their participation and productivity.
